Get v6.4 [Software]

posted by Artem Gusev  – Russia, Moscow, 2017-04-27 11:12 (2844 d 18:56 ago) – Posting: # 17274
Views: 6,407

(edited on 2017-04-27 11:32)

Dear Helmut!

Thank you for quick response.
I want to clarify one more point. I need to calculate additional parameter in ANOVA - Cohort factor.

Then in the case of a EMA Model Specification is:
sequence+subject(sequence)+period+treatment+cohort
Am I right?

And how Model Specification can be constructed for agencies recommending a mixed-effects model (FDA, Health Canada)?

Thank you!


Edit: This thread gets less software-related. I opened a new thread for answers. [Helmut]

Best Regards,
Artem

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,665 registered users;
145 visitors (0 registered, 145 guests [including 7 identified bots]).
Forum time: 05:09 CET (Europe/Vienna)

There are sadistic scientists who hurry to hunt down errors
instead of establishing the truth.    Marie Curie

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5